Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea
· Delayed Price · Currency is KRW 16,160
0.00 (0.00%)
At close: Mar 21, 2025, 3:30 PM KST
Sam-A Pharm. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 95,581 | 97,211 | 81,700 | 54,666 | 53,653 | Upgrade
|
| Other Revenue | - | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 95,581 | 97,211 | 81,700 | 54,666 | 53,653 | Upgrade
|
| Revenue Growth (YoY) | -1.68% | 18.99% | 49.45% | 1.89% | -25.02% | Upgrade
|
| Cost of Revenue | 34,929 | 35,932 | 31,537 | 22,009 | 21,283 | Upgrade
|
| Gross Profit | 60,651 | 61,279 | 50,163 | 32,658 | 32,370 | Upgrade
|
| Selling, General & Admin | 28,367 | 29,123 | 26,661 | 20,814 | 22,780 | Upgrade
|
| Research & Development | 5,421 | 6,398 | 3,771 | 3,829 | 3,681 | Upgrade
|
| Other Operating Expenses | 113.79 | 164.66 | - | - | - | Upgrade
|
| Operating Expenses | 36,185 | 37,779 | 31,909 | 26,610 | 28,439 | Upgrade
|
| Operating Income | 24,466 | 23,500 | 18,253 | 6,048 | 3,930 | Upgrade
|
| Interest Expense | -538.22 | -219.74 | -63.43 | -125.62 | -202.94 | Upgrade
|
| Interest & Investment Income | 5,465 | 4,644 | 2,432 | 1,503 | 1,934 | Upgrade
|
| Earnings From Equity Investments | -932.85 | -915.83 | -1,290 | -2,464 | -4,195 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.22 | -0.04 | 34.61 | 111.9 | -147.12 | Upgrade
|
| Other Non Operating Income (Expenses) | 413.63 | 390.28 | 356.41 | 236.28 | 289.04 | Upgrade
|
| EBT Excluding Unusual Items | 28,866 | 27,399 | 19,722 | 5,309 | 1,609 | Upgrade
|
| Gain (Loss) on Sale of Investments | 340.91 | 699.03 | - | 16.65 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 63.44 | 383.34 | 13.05 | 334.04 | 181.1 | Upgrade
|
| Asset Writedown | - | -5.49 | -1,335 | -325.17 | -216.52 | Upgrade
|
| Pretax Income | 29,270 | 28,476 | 18,400 | 5,335 | 1,573 | Upgrade
|
| Income Tax Expense | 7,190 | 7,102 | 6,488 | 1,943 | 1,450 | Upgrade
|
| Net Income | 22,080 | 21,374 | 11,912 | 3,392 | 123.85 | Upgrade
|
| Net Income to Common | 22,080 | 21,374 | 11,912 | 3,392 | 123.85 | Upgrade
|
| Net Income Growth | 3.30% | 79.44% | 251.22% | 2638.34% | -98.78% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | - | - | - | Upgrade
|
| EPS (Basic) | 3618.00 | 3502.00 | 1951.65 | 555.68 | 20.29 | Upgrade
|
| EPS (Diluted) | 3618.00 | 3502.00 | 1951.65 | 555.68 | 20.00 | Upgrade
|
| EPS Growth | 3.31% | 79.44% | 251.22% | 2678.42% | -98.80% | Upgrade
|
| Free Cash Flow | 18,735 | 16,940 | 19,365 | 12,667 | 8,728 | Upgrade
|
| Free Cash Flow Per Share | 3069.99 | 2775.58 | 3172.89 | 2075.46 | 1430.09 | Upgrade
|
| Dividend Per Share | - | - | 400.000 | 250.000 | 300.000 | Upgrade
|
| Dividend Growth | - | - | 60.00% | -16.67% | - | Upgrade
|
| Gross Margin | 63.46% | 63.04% | 61.40% | 59.74% | 60.33% | Upgrade
|
| Operating Margin | 25.60% | 24.17% | 22.34% | 11.06% | 7.33% | Upgrade
|
| Profit Margin | 23.10% | 21.99% | 14.58% | 6.20% | 0.23% | Upgrade
|
| Free Cash Flow Margin | 19.60% | 17.43% | 23.70% | 23.17% | 16.27% | Upgrade
|
| EBITDA | 28,733 | 27,395 | 21,440 | 9,747 | 7,821 | Upgrade
|
| EBITDA Margin | 30.06% | 28.18% | 26.24% | 17.83% | 14.58% | Upgrade
|
| D&A For EBITDA | 4,266 | 3,895 | 3,187 | 3,699 | 3,891 | Upgrade
|
| EBIT | 24,466 | 23,500 | 18,253 | 6,048 | 3,930 | Upgrade
|
| EBIT Margin | 25.60% | 24.17% | 22.34% | 11.06% | 7.33% | Upgrade
|
| Effective Tax Rate | 24.57% | 24.94% | 35.26% | 36.43% | 92.13% | Upgrade
|
| Advertising Expenses | 7,031 | 6,787 | 5,966 | 4,174 | 4,532 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.